Books > Medicine > Clinical & internal medicine > Ophthalmology
|
Buy Now
Age-Related Macular Degeneration - Current Management (Paperback)
Loot Price: R3,022
Discovery Miles 30 220
|
|
Age-Related Macular Degeneration - Current Management (Paperback)
Expected to ship within 12 - 17 working days
|
Retinal disease in general, and age-related macular degeneration
(AMD) specifically, is of major interest worldwide due to the
increasing aging population and the revolution in management of wet
AMD over the past several years. Age-Related Macular Degeneration
presents an up-to-date, clinically relevant monograph on the
current diagnosis and management of AMD. Age-Related Macular
Degeneration by Drs. Jay S. Duker and Andre J. Witkin serves as a
reference for ophthalmologists treating AMD in the clinic as well
as other eye care professionals who see and counsel patients with
AMD. Chapters will focus on the pathogenesis and risk factors for
AMD, the diagnosis of AMD, treatment options, and promising
investigative interventions. To help readers gain familiarity
recognizing AMD, the book contains multiple images in different
formats: high quality color fundus photographs, black- and-white
angiograms, black-and-white autofluorence images, and both color
and black-and-white OCT images. Relevant to current management of
AMD, Age-Related Macular Degeneration: Current Management
concentrates on "clinical utility" rather than emphasizing
published studies, filling the current void in the market for the
general ophthalmology and optometry audience. Comprehensive
ophthalmologists, optometrists and retinal specialists will
appreciate the book's practical approach to AMD.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.